BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 24497266)

  • 21. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
    Mitchell HR; Lu X; Myers RM; Sung L; Balsamo LM; Carroll WL; Raetz E; Loh ML; Mattano LA; Winick NJ; Devidas M; Hunger SP; Maloney K; Kadan-Lottick NS
    Int J Cancer; 2016 Jan; 138(2):332-9. PubMed ID: 26235006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation.
    Précourt S; Robaey P; Lamothe I; Lassonde M; Sauerwein HC; Moghrabi A
    Dev Neuropsychol; 2002; 21(2):173-95. PubMed ID: 12139198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
    Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
    Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
    Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
    JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential gonadotoxicity of treatment in relation to quality of life and mental well-being of male survivors of childhood acute lymphoblastic leukemia.
    Gunn ME; Lähteenmäki PM; Puukko-Viertomies LR; Henriksson M; Heikkinen R; Jahnukainen K
    J Cancer Surviv; 2013 Sep; 7(3):404-12. PubMed ID: 23604999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children.
    Kaemingk KL; Carey ME; Moore IM; Herzer M; Hutter JJ
    Child Neuropsychol; 2004 Mar; 10(1):14-23. PubMed ID: 14977512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Liu H; Chen L; Nicoletti M; Stork L; Bostrom B; Neglia JP
    Blood; 2009 Aug; 114(9):1746-52. PubMed ID: 19546477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.
    Link K; Moëll C; Osterberg K; Persson R; Ørbaek P; Garwicz S; Cavallin-Ståhl E; Erfurth EM
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):617-25. PubMed ID: 17054463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia: experience at a tertiary care hospital in Korea.
    Kim SJ; Park MH; Lee JW; Chung NG; Cho B; Lee IG; Chung SY
    J Korean Med Sci; 2015 Apr; 30(4):463-9. PubMed ID: 25829815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
    Chiou SS; Lin PC; Liao YM; Yang P
    Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
    Zheng DJ; Lu X; Schore RJ; Balsamo L; Devidas M; Winick NJ; Raetz EA; Loh ML; Carroll WL; Sung L; Hunger SP; Angiolillo AL; Kadan-Lottick NS
    Cancer; 2018 Feb; 124(3):571-579. PubMed ID: 29112230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life during active treatment for pediatric acute lymphoblastic leukemia.
    Sung L; Yanofsky R; Klaassen RJ; Dix D; Pritchard S; Winick N; Alexander S; Klassen A
    Int J Cancer; 2011 Mar; 128(5):1213-20. PubMed ID: 20473921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life of children with acute lymphoblastic leukaemia: comparisons and correlations between parent and clinician reports.
    Waters EB; Wake MA; Hesketh KD; Ashley DM; Smibert E
    Int J Cancer; 2003 Feb; 103(4):514-8. PubMed ID: 12478668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia.
    Jain N; Brouwers P; Okcu MF; Cirino PT; Krull KR
    Cancer; 2009 Sep; 115(18):4238-45. PubMed ID: 19536898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.